Image coming soon

IPRATROPIUM INHALATION NEBULES 250MCG/ML,20CT

₦7,450.00

(No reviews yet) Write a Review

SKU:: 16922
UPC:

Current Stock:

Related Products

Ventolin Nebules are indicated in adults, adolescents and children aged 4 to 11 years. For babies and children under 4 years of age,

Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction.

Ventolin Nebules are indicated for use in the routine management of chronic bronchospasm unresponsive to conventional therapy, and in the treatment of acute severe asthma.

VENTOLIN 2.5MG NEBULES,20CT

₦5,950.00

VENTOLIN (SALBUTAMOL) 5MG NEBULES,20CT

VENTOLIN (SALBUTAMOL) 5MG NEBULES,20CT

₦16,200.00

ATROVENT 500 UDVs, 2ml are indicated for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease and, when used concomitantly with inhaled beta2-agonists, for treatment of acute and chronic asthma and acute bronchospasm associated with chronic obstructive pulmonary disease. — Add to Cart The item has been added

ATROVENT(IPRATROPIUM BROMIDE) STREI-NEBS 500MCG/2ML,20CT

₦21,000.00

COPD

Tiotropium is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).

Asthma

Spiriva Respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year (see sections 4.2 and 5.1). — Add to Cart The item has been added

SPIRIVA RESPIMAT INHALER CARTRIDGE, 1PACK

₦96,500.00

Asthma

Fostair NEXThaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:

- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or

- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

Fostair NEXThaler is indicated for adult patients.

COPD

Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

FOSTAIR NEXT 100/6 INHALER

₦74,500.00